JP2021535226A5 - - Google Patents

Info

Publication number
JP2021535226A5
JP2021535226A5 JP2021536679A JP2021536679A JP2021535226A5 JP 2021535226 A5 JP2021535226 A5 JP 2021535226A5 JP 2021536679 A JP2021536679 A JP 2021536679A JP 2021536679 A JP2021536679 A JP 2021536679A JP 2021535226 A5 JP2021535226 A5 JP 2021535226A5
Authority
JP
Japan
Prior art keywords
composition according
substituted
lipids
composition
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021536679A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021535226A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/049552 external-priority patent/WO2020051220A1/en
Publication of JP2021535226A publication Critical patent/JP2021535226A/ja
Publication of JP2021535226A5 publication Critical patent/JP2021535226A5/ja
Priority to JP2025064066A priority Critical patent/JP2025108518A/ja
Pending legal-status Critical Current

Links

JP2021536679A 2018-09-04 2019-09-04 核酸を臓器特異的送達するための組成物および方法 Pending JP2021535226A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025064066A JP2025108518A (ja) 2018-09-04 2025-04-09 核酸を臓器特異的送達するための組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862726770P 2018-09-04 2018-09-04
US62/726,770 2018-09-04
PCT/US2019/049552 WO2020051220A1 (en) 2018-09-04 2019-09-04 Compositions and methods for organ specific delivery of nucleic acids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025064066A Division JP2025108518A (ja) 2018-09-04 2025-04-09 核酸を臓器特異的送達するための組成物および方法

Publications (2)

Publication Number Publication Date
JP2021535226A JP2021535226A (ja) 2021-12-16
JP2021535226A5 true JP2021535226A5 (cg-RX-API-DMAC7.html) 2022-09-14

Family

ID=69721690

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021536679A Pending JP2021535226A (ja) 2018-09-04 2019-09-04 核酸を臓器特異的送達するための組成物および方法
JP2025064066A Pending JP2025108518A (ja) 2018-09-04 2025-04-09 核酸を臓器特異的送達するための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025064066A Pending JP2025108518A (ja) 2018-09-04 2025-04-09 核酸を臓器特異的送達するための組成物および方法

Country Status (8)

Country Link
US (2) US11766408B2 (cg-RX-API-DMAC7.html)
EP (1) EP3846857A4 (cg-RX-API-DMAC7.html)
JP (2) JP2021535226A (cg-RX-API-DMAC7.html)
CN (2) CN120360966A (cg-RX-API-DMAC7.html)
AU (2) AU2019335055B2 (cg-RX-API-DMAC7.html)
CA (1) CA3111483A1 (cg-RX-API-DMAC7.html)
GB (3) GB2600800B (cg-RX-API-DMAC7.html)
WO (1) WO2020051220A1 (cg-RX-API-DMAC7.html)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102764250B1 (ko) * 2015-09-14 2025-02-07 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 지질양이온성 덴드리머 및 이의 용도
CA3025626A1 (en) 2016-05-27 2017-11-30 Transcriptx, Inc. Treatment of primary ciliary dyskinesia with synthetic messenger rna
EP3658168A4 (en) 2017-06-30 2021-07-14 Duke University ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-RESPONDING BIOPOLYMER NETWORKS
US12357580B2 (en) 2018-06-19 2025-07-15 The Board Of Regents Of The University Of Texas System Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids
GB2606038B (en) 2018-09-04 2023-05-03 Univ Texas Compositions and methods for organ specific delivery of nucleic acids
GB2600800B (en) 2018-09-04 2023-08-16 Univ Texas Compositions and methods for organ specific delivery of nucleic acids
WO2020051541A1 (en) 2018-09-07 2020-03-12 Duke University Nanoparticulate drug delivery systems
DK3864163T3 (da) * 2018-10-09 2024-05-06 Univ British Columbia Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
US20240293317A1 (en) * 2020-04-20 2024-09-05 Board Of Regents, The University Of Texas System Lipid nanoparticle (lnp) delivery systems and uses thereof
EP4153560A4 (en) * 2020-05-19 2024-04-24 Ramot at Tel-Aviv University Ltd. LIPID PARTICLES FOR NUCLEIC ACID DELIVERY AND CLINICAL APPLICATIONS THEREOF
AU2021400582A1 (en) * 2020-12-18 2023-07-06 Flagship Labs 114, Inc. Tissue-specific nucleic acid delivery by 1,2-dioleoyl-3-trimethylammonium-propane (dotap) lipid nanoparticles
WO2022204043A1 (en) * 2021-03-22 2022-09-29 The Board Of Regents Of The University Of Texas System Compositions and methods for targeted delivery to cells
MX2023011227A (es) * 2021-03-22 2023-12-06 Recode Therapeutics Inc Composiciones y metodos para administracion dirigida a celulas.
IL305958A (en) * 2021-03-22 2023-11-01 Recode Therapeutics Inc Polynucleotide preparations, related formulations and methods of using them
MX2023011243A (es) 2021-03-23 2023-12-14 Recode Therapeutics Inc Composiciones de polinucleotidos, formulaciones relacionadas y metodos de uso de los mismos.
KR20240024041A (ko) * 2021-03-23 2024-02-23 리코드 테라퓨틱스, 인크. 세포로의 표적화 전신 전달을 위한 조성물 및 방법
CN117750948A (zh) * 2021-03-23 2024-03-22 瑞科德治疗公司 用于靶向全身性递送至细胞的组合物和方法
US20220347112A1 (en) * 2021-03-31 2022-11-03 Rejuvenation Technologies Inc. Compositions and methods for delivery of rna
JP2024516164A (ja) * 2021-04-22 2024-04-12 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 正確なインビボhdr介在性遺伝子編集を可能にするオールインワンデンドリマーベース脂質ナノ粒子
US20240197636A1 (en) * 2021-04-22 2024-06-20 Omega Therapeutics, Inc. Tissue-specific nucleic acid delivery by mixed cationic lipid particles
CN113402404B (zh) * 2021-04-30 2022-03-11 苏州科锐迈德生物医药科技有限公司 脂质化合物及包含其的脂质载体、核酸脂质纳米粒组合物和药物制剂
EP4422605A4 (en) * 2021-10-25 2025-06-18 Duke University Poegma-based lipid nanoparticles
WO2023092218A1 (en) * 2021-11-23 2023-06-01 The University Of British Columbia Methods and compositions for modulating fibrinogen
WO2023165583A1 (zh) * 2022-03-04 2023-09-07 益杰立科(上海)生物科技有限公司 靶向眼部细胞的递送系统和方法
US12011507B2 (en) 2022-04-01 2024-06-18 Nanovation Therapeutics Inc. MRNA delivery composition
CN114891808B (zh) * 2022-06-21 2023-10-27 珠海丽凡达生物技术有限公司 编码ALDH2多肽的mRNA分子、应用及mRNA药物
CN119486721A (zh) 2022-07-08 2025-02-18 宝利普拉斯生物转染公司 包含基于咪唑鎓的阳离子脂质的脂质纳米颗粒
WO2024012270A1 (zh) * 2022-07-11 2024-01-18 传信生物医药(苏州)有限公司 用于核酸的器官特异性递送组合物
CN120112275A (zh) * 2022-08-25 2025-06-06 俄亥俄州创新基金会 用于递送包括核酸的活性剂的组合物和方法
CN116763756A (zh) * 2022-10-11 2023-09-19 中国科学院化学研究所 一种脂质纳米颗粒及其制备方法和应用
WO2024086929A1 (en) * 2022-10-25 2024-05-02 Nanovation Therapeutics Inc. Lipid nanoparticle formulations for anti-sense oligonucleotide delivery
CN116236565B (zh) * 2022-11-21 2025-06-27 成都诺恩生物科技有限公司 适合于肌注给药的核酸-脂质纳米颗粒、制剂及其应用
JP2025538636A (ja) * 2022-11-24 2025-11-28 ザミディアム セラピューティクス カンパニー リミテッド 核酸送達のための新規脂質及び脂質ナノ粒子組成物
EP4630061A1 (en) * 2022-12-08 2025-10-15 Nanovation Therapeutics Inc. Lipid nanoparticles comprising elevated neutral lipid and a targeting moiety for targeted delivery of nucleic acid
IL321026A (en) 2022-12-08 2025-07-01 Recode Therapeutics Inc Nanoparticle formulations and their uses
CN118236344A (zh) * 2022-12-15 2024-06-25 深圳瑞吉生物科技有限公司 一种核酸脂质纳米载体及其制备方法与应用
US20260209255A1 (en) * 2022-12-23 2026-07-23 Turn Biotechnologies, Inc. Dual lipid structures
CN117771213A (zh) * 2023-01-10 2024-03-29 北京剂泰医药科技有限公司 脂质纳米颗粒组合物及其用途
JP2026503676A (ja) * 2023-01-27 2026-01-29 セイル バイオメディシンズ インコーポレイテッド 修飾脂質組成物およびその使用
WO2024215257A1 (en) * 2023-04-13 2024-10-17 National University Of Singapore Polymersomes and methods of using and making the same
CN116271105B (zh) * 2023-05-18 2023-08-25 上海贝斯昂科生物科技有限公司 一种适于rpe细胞转染的脂质纳米颗粒及其应用
CN116731010B (zh) * 2023-06-08 2025-02-11 西南大学 长春胺类衍生物及其制备方法和应用
CN119143620A (zh) 2023-06-16 2024-12-17 北京剂泰医药科技有限公司 一种快速代谢的脂质化合物
AR134146A1 (es) * 2023-10-24 2025-12-03 Green Cross Corp Lípidos ionizables y usos de los mismos
WO2025117816A1 (en) * 2023-12-01 2025-06-05 Recode Therapeutics, Inc. Lipid nanoparticle compositions and uses thereof
US12553042B2 (en) 2023-12-01 2026-02-17 Recode Therapeutics, Inc. Method for quantifying an amount of capped messenger RNA
US12364773B2 (en) 2023-12-01 2025-07-22 Recode Therapeutics, Inc. Lipid nanoparticle compositions and uses thereof
WO2025124560A1 (zh) 2023-12-13 2025-06-19 上海瑞宏迪医药有限公司 用于递送治疗剂的组合物和化合物
WO2025137646A1 (en) * 2023-12-22 2025-06-26 Recode Therapeutics, Inc. Gene editing methods and compositions for treating cystic fibrosis
CN118001254B (zh) * 2024-04-09 2024-07-26 北京悦康科创医药科技股份有限公司 靶向抗原呈递细胞的脂质组合物及其应用
WO2025228979A1 (en) 2024-04-30 2025-11-06 Neovac Ltd. Lipids nanoparticle formulations suitable for lung targeting
WO2025240356A1 (en) * 2024-05-14 2025-11-20 Recode Therapeutics, Inc. Lipid nanoparticles for hepatic delivery
WO2025264646A2 (en) * 2024-06-17 2025-12-26 The Board Of Regents Of The University Of Texas System Direct in vivo gene editing of lung stem cells for durable therapy of genetic lung disease
WO2026003403A1 (en) 2024-06-28 2026-01-02 Certest Biotec, S.L. Ionizable lipids and lipid nanoparticles containing them for extrahepatic delivery
CN118750468B (zh) * 2024-09-05 2025-02-18 北京悦康科创医药科技股份有限公司 一种核酸-脂质纳米颗粒冻干组合物及其制备方法和应用
WO2026062291A1 (en) 2024-09-23 2026-03-26 Aldexchem Kft. Silicon-containing spleen-targeted lnp delivery systems
EP4775566A1 (en) 2025-01-10 2026-07-15 Syvento Sp. Z O.O. Compounds for encapsulation and delivery
WO2026150089A1 (en) 2025-01-10 2026-07-16 Syvento Sp. Z O. O Compounds for encapsulation and delivery

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5820873A (en) 1994-09-30 1998-10-13 The University Of British Columbia Polyethylene glycol modified ceramide lipids and liposome uses thereof
US7053150B2 (en) 2000-12-18 2006-05-30 Nektar Therapeutics Al, Corporation Segmented polymers and their conjugates
US7314956B2 (en) 2001-08-08 2008-01-01 Vaxim, Inc. Multifunctional carrier for the delivery of a pharmacological agent or genetic material into a cell
US8871709B2 (en) 2003-02-05 2014-10-28 Queensland University of Technolgy Synthetic chimeric proteins comprising epidermal growth factor and vitronectin
US7985424B2 (en) 2004-04-20 2011-07-26 Dendritic Nanotechnologies Inc. Dendritic polymers with enhanced amplification and interior functionality
DK1771206T3 (en) 2004-05-05 2018-05-22 Silence Therapeutics Gmbh LIPIDS, LIPID COMPLEXES AND USE THEREOF
CA2569664C (en) 2004-06-07 2013-07-16 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna
US7404969B2 (en) 2005-02-14 2008-07-29 Sirna Therapeutics, Inc. Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
WO2006138380A2 (en) 2005-06-15 2006-12-28 Massachusetts Institute Of Technology Amine-containing lipids and uses thereof
US20090221684A1 (en) 2005-12-22 2009-09-03 Trustees Of Boston University Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof
EP2046266A4 (en) 2006-07-21 2009-11-04 Massachusetts Inst Technology ENDMODICIFIED POLY (BETA AMINO ESTER) AND ITS USE
WO2009111088A2 (en) * 2008-01-02 2009-09-11 The Johns Hopkins University Antitumor immunization by liposomal delivery of vaccine to the spleen
EP2279254B1 (en) 2008-04-15 2017-07-05 Protiva Biotherapeutics Inc. Novel lipid formulations for nucleic acid delivery
WO2010053572A2 (en) 2008-11-07 2010-05-14 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
US8163861B2 (en) 2009-01-15 2012-04-24 Living Proof, Inc. Beta-amino ester compounds and uses thereof
CA2763819A1 (en) 2009-06-02 2010-12-09 Nian WU Pure peg-lipid conjugates
CN101591428B (zh) 2009-06-29 2011-05-25 浙江大学 一种聚酯树枝状大分子的制备方法
CN103153284B (zh) * 2010-07-06 2015-11-25 诺华股份有限公司 含有其pKa值有利于RNA递送的脂质的脂质体
CA2807139A1 (en) * 2010-07-31 2012-02-09 The Scripps Research Institute Liposome targeting compounds and related uses
WO2012090223A1 (en) 2010-12-29 2012-07-05 Indian Institute Of Science Poly(ether imine) dendrimers and uses thereof
KR20220025112A (ko) * 2011-06-08 2022-03-03 샤이어 휴먼 지네틱 테라피즈 인크. Mrna 전달을 위한 지질 나노입자 조성물 및 방법
CN107043334B (zh) 2011-06-08 2020-06-16 日东电工株式会社 用于定向药物输送和增强siRNA活性的化合物
AU2012325997C1 (en) * 2011-10-18 2018-07-05 Dicerna Pharmaceuticals, Inc. Amine cationic lipids and uses thereof
BR112014024131A2 (pt) * 2012-03-29 2017-07-25 Shire Human Genetic Therapies lipídios catiônicos ionizáveis
CA2874490C (en) * 2012-05-23 2021-11-16 The Ohio State University Tertiary quaternary amine-based cationic lipid nanoparticle compositions and methods of making and methods of using the same
CN104781276A (zh) 2012-08-14 2015-07-15 安吉奥开米公司 肽-树枝状聚合物结合物及其用途
AU2013380825B2 (en) * 2012-10-16 2017-07-20 Biomics Biotechnologies Co., Ltd. Lipidosome preparation, preparation method and application thereof
JP6241193B2 (ja) 2012-10-23 2017-12-06 コニカミノルタ株式会社 透明電極、電子デバイス及び有機エレクトロルミネッセンス素子
HK1217085A1 (zh) * 2012-12-28 2016-12-23 Tarveda Therapeutics, Inc 包封在顆粒中的靶向綴合物及其製劑
US20140186332A1 (en) 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth
ES2967701T3 (es) 2013-03-15 2024-05-03 Translate Bio Inc Mejora sinergística de la entrega de ácidos nucleicos mediante formulaciones mezcladas
ES2707966T3 (es) 2013-10-22 2019-04-08 Translate Bio Inc Terapia de ARNm para la deficiencia en síntesis de argininosuccinato
CN111206032B (zh) * 2013-12-12 2024-07-19 布罗德研究所有限公司 用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用
PL3122878T3 (pl) 2014-03-24 2019-06-28 Translate Bio, Inc. TERAPIA mRNA DO LECZENIA CHORÓB OCZU
WO2015154002A1 (en) * 2014-04-04 2015-10-08 Ohio State Innovation Foundation Oligonucleotide lipid nanoparticle compositions, methods of making and methods of using the same
HRP20220070T1 (hr) * 2014-04-23 2022-04-01 Modernatx, Inc. Cjepiva nukleinske kiseline
WO2015191693A2 (en) * 2014-06-10 2015-12-17 Massachusetts Institute Of Technology Method for gene editing
CN103999853B (zh) 2014-06-11 2015-07-22 中国农业大学 荧光树枝状纳米大分子在制备药物载体中的应用
CN106794141B (zh) * 2014-07-16 2021-05-28 诺华股份有限公司 将核酸包封在脂质纳米粒主体中的方法
CN107530399B (zh) * 2014-10-10 2022-03-18 马萨诸塞眼科耳科诊所 治疗分子在体外和体内的有效递送
AU2015357562B2 (en) 2014-12-05 2021-10-21 Translate Bio, Inc. Messenger RNA therapy for treatment of articular disease
AU2015360794B2 (en) 2014-12-08 2021-07-08 The Board Of Regents Of The University Of Texas System Lipocationic polymers and uses thereof
EP3247328B1 (en) * 2015-01-21 2026-01-07 Genevant Sciences Gmbh Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
EP3247398A4 (en) * 2015-01-23 2018-09-26 Moderna Therapeutics, Inc. Lipid nanoparticle compositions
KR102764250B1 (ko) * 2015-09-14 2025-02-07 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 지질양이온성 덴드리머 및 이의 용도
US20180258411A1 (en) * 2015-09-25 2018-09-13 Tarveda Therapeutics, Inc. Compositions and methods for genome editing
ES3030658T3 (en) * 2016-03-30 2025-07-01 Intellia Therapeutics Inc Lipid nanoparticle formulations for crispr/cas components
EP3442590A2 (en) * 2016-04-13 2019-02-20 Modernatx, Inc. Lipid compositions and their uses for intratumoral polynucleotide delivery
PL3458074T3 (pl) 2016-05-16 2024-11-12 Board Of Regents Of The University Of Texas System KOMPOZYCJA DO DOSTARCZANIA tRNA W POSTACI NANOCZĄSTEK I SPOSOBY ICH STOSOWANIA
PL3458083T3 (pl) * 2016-05-18 2023-03-13 Modernatx, Inc. Polinukleotydy kodujące interleukinę-12 (il12) i ich zastosowania
CN109562153A (zh) * 2016-08-07 2019-04-02 诺华股份有限公司 mRNA介导的免疫方法
KR20190093816A (ko) * 2016-10-26 2019-08-26 큐어백 아게 지질 나노입자 mRNA 백신
EP3315125A1 (en) * 2016-10-31 2018-05-02 Silence Therapeutics (London) Ltd Lipid nanoparticle formulation
GB2596224B (en) * 2018-06-19 2022-09-07 Univ Texas Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids
GB2600800B (en) 2018-09-04 2023-08-16 Univ Texas Compositions and methods for organ specific delivery of nucleic acids
GB2606038B (en) * 2018-09-04 2023-05-03 Univ Texas Compositions and methods for organ specific delivery of nucleic acids

Similar Documents

Publication Publication Date Title
JP2021535227A5 (cg-RX-API-DMAC7.html)
JP2024016183A5 (cg-RX-API-DMAC7.html)
GB2592505A (en) Compositions and methods for organ specific delivery of nucleic acids
JP2025181861A5 (cg-RX-API-DMAC7.html)
US20240083842A1 (en) Lipocationic dendrimers and uses thereof
GB2592504A (en) Compositions and methods for organ specific delivery of nucleic acids
JP2022031692A5 (cg-RX-API-DMAC7.html)
JP2025175052A5 (cg-RX-API-DMAC7.html)
US10933081B2 (en) Myostatin iRNA compositions and methods of use thereof
BR112014016562B1 (pt) Estrutura de oligo-rna de dupla hélice, nanopartícula e método de preparação
US20240207187A1 (en) Dendritic architectures as nonviral vectors in gene delivery
US20250354174A1 (en) Nanoparticle compositions containing sugar functionalized nucleic acid carriers
CN118105357B (zh) 一种鞘内递送制剂及其用途
JP2009502765A (ja) 新規なカルボシランデンドリマー、その調製方法及びその使用
EP4472671A1 (en) Poly(alkyloxazoline)-lipid conjugates and lipid particles containing same
BR112021011018A2 (pt) Conjugados de oligômero para exon skipping para distrofia muscular
TW202449155A (zh) 用於肌肉萎縮症之外顯子跳躍寡聚物
KR102570826B1 (ko) Covid-19를 포함하는 호흡기 바이러스 감염증, 바이러스 감염에 의한 폐섬유증, 또는 호흡기 질환 예방 또는 치료를 위한 초음파 방식 연무식 흡입기를 이용한 이중가닥 올리고뉴클레오티드 구조체 투여용 조성물
JP2025540278A (ja) 修飾免疫調節薬
JP2025540076A (ja) 核酸、イオン化可能な脂質、ステロール、脂質アンカーポリマー、及びヘルパー脂質を含む脂質ナノ粒子、それらの使用
KR102320650B1 (ko) 혈뇌장벽 투과능을 가지는 펩티드 핵산 복합체 및 이를 포함하는 조성물
JP2023545418A (ja) 一置換ホモ二価リンカーを含むマルチコンジュゲート
WO2026090175A2 (en) Propargyl amino-ionizable lipid compounds, lipid nanoparticles (lnps), and methods of making and using same for gene editing
WO2024183497A1 (zh) 一种鞘内递送制剂及其用途